ShashankChetty | Nanotechnology | Best Researcher Award

Dr. Shashank Chetty , Stanford University, United States.

Dr. Shashank Chetty is a dedicated researcher at Stanford University, specializing in nanoscience and technology. He holds a Ph.D. in Nanoscience and Technology from Pondicherry University, focusing on nanocrystals for multimodal diagnostics and regenerative therapies. Currently a Post-Doctoral Researcher at Stanford’s School of Medicine, he explores pulsed focused ultrasound technology to enhance mesenchymal stem cell therapies for kidney injury, diabetes, and ARDS. Dr. Chetty’s work is pivotal in advancing therapeutic applications of stem cells and extracellular vesicles.

Publication Profile

Orcid

Google Scholar

Education and Experience:

Dr. Chetty completed his B.Tech in Biotechnology at PSG College of Technology and M.Tech at Pondicherry University, excelling in rapid nanocrystal synthesis. His Ph.D. research, supervised by Prof. A. Vadivel Murugan, pioneered microwave-solvothermal synthesis for imaging applications. He has garnered prestigious awards, including Stanford’s Maternal and Child Health Research Institute Award, recognizing his contributions to regenerative medicine.

Professional Development

Dr. Chetty’s career spans teaching nanoscience courses and mentoring STEM interns. His research focuses on integrating nanotechnology with stem cell therapies, enhancing diagnostic imaging and regenerative capabilities. He contributes significantly to NIH-funded projects, such as CRISPR-Cas editing for polycystic kidney disease and modulating heat shock proteins for acute kidney injury treatment. His work underscores a commitment to innovative biomedical solutions and educational outreach in science.

Research Focus:

Dr. Chetty’s research focuses on leveraging nanotechnology and ultrasound techniques to enhance the therapeutic efficacy of mesenchymal stem cells and extracellular vesicles. His work aims to develop novel treatments for kidney injury, diabetes, and acute respiratory distress syndrome (ARDS), aiming to improve patient outcomes through innovative biomedical approaches.